nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A NEWral approach for HSC production in vitro?
|
Petazzi, Paolo |
|
|
136 |
25 |
p. 2845-2847 |
artikel |
2 |
Cerebral microbleeds in ITP: alarming or innocent?
|
Rodeghiero, Francesco |
|
|
136 |
25 |
p. 2842-2844 |
artikel |
3 |
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL
|
Haselager, Marco V. |
|
|
136 |
25 |
p. 2918-2926 |
artikel |
4 |
Chromosome 20 loss is characteristic for BIA-ALCL
|
|
|
|
136 |
25 |
p. 2966 |
artikel |
5 |
Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma
|
Los-de Vries, G. Tjitske |
|
|
136 |
25 |
p. 2927-2932 |
artikel |
6 |
Chromosomes in breast lymphoma
|
de Leval, Laurence |
|
|
136 |
25 |
p. 2848-2849 |
artikel |
7 |
Combinatorial treatment with menin and FLT3 inhibitors induces complete remission in AML models with activating FLT3 mutations
|
Miao, Hongzhi |
|
|
136 |
25 |
p. 2958-2963 |
artikel |
8 |
Dosing-related saturation of toxicity and accelerated drug clearance with pegaspargase treatment
|
Liu, Yiwei |
|
|
136 |
25 |
p. 2955-2958 |
artikel |
9 |
Editorial Board
|
|
|
|
136 |
25 |
p. i |
artikel |
10 |
Elusive sentinels at the Hodgkin checkpoint
|
Younes, Sheren |
|
|
136 |
25 |
p. 2841-2842 |
artikel |
11 |
Expanding the toolbox to combat a pandemic
|
Prockop, Susan E. |
|
|
136 |
25 |
p. 2847-2848 |
artikel |
12 |
FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus
|
Melki, Imene |
|
|
136 |
25 |
p. 2933-2945 |
artikel |
13 |
García-García A, Korn C, García-Fernández M, et al. Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes. Blood. 2019;133(3):224-236.
|
|
|
|
136 |
25 |
p. 2965 |
artikel |
14 |
Identification of occult cerebral microbleeds in adults with immune thrombocytopenia
|
Cooper, Nichola |
|
|
136 |
25 |
p. 2875-2880 |
artikel |
15 |
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|
Vijenthira, Abi |
|
|
136 |
25 |
p. 2881-2892 |
artikel |
16 |
SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
|
Keller, Michael D. |
|
|
136 |
25 |
p. 2905-2917 |
artikel |
17 |
Severe transient pancytopenia with dyserythropoiesis and dysmegakaryopoiesis in COVID-19–associated MIS-C
|
Mariani, Rachel |
|
|
136 |
25 |
p. 2964 |
artikel |
18 |
Single-cell analyses and machine learning define hematopoietic progenitor and HSC-like cells derived from human PSCs
|
Fidanza, Antonella |
|
|
136 |
25 |
p. 2893-2904 |
artikel |
19 |
Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency
|
Strilchuk, Amy W. |
|
|
136 |
25 |
p. 2946-2954 |
artikel |
20 |
The relationship between ABO blood group, von Willebrand factor, and primary hemostasis
|
Ward, Soracha E. |
|
|
136 |
25 |
p. 2864-2874 |
artikel |
21 |
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1
|
Reinke, Sarah |
|
|
136 |
25 |
p. 2851-2863 |
artikel |
22 |
Under COVID of the night
|
Sekeres, Mikkael A. |
|
|
136 |
25 |
p. 2844-2845 |
artikel |